Truetide’s Paraytec completes phase 2 of lung cancer study
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Health & Medicine
OMass Therapeutics collects $310M to chase Neurocrine, Vertex in genetic adrenal disorder
An Oxford-based drug developer has raised one of the largest private financings for a UK biotech in recent years as it seeks to follow in the footsteps of Neurocrine and Vertex-acquired Crinetics in…
Bird flu detected in seal, bird samples taken from remote southern island
Bird flu has been detected in samples taken from a southern elephant seal and a kelp gull on Macquarie Island, with authorities making preparations for a mass mortality event.
Pharma: Investors wanted to buy former Curevac plant - Biontech prefers to close it down
Internal documents suggest that the vaccine manufacturer negotiated for months about the sale of its mRNA laboratories in Tübingen - and then broke off. The million-dollar offer had a catch.
Drugmaker Yuhan's historic headquarters wins Korea's top architectural honor
Willow House, the historical former headquarters of Korean pharmaceutical pioneer Yuhan Corp., has won the Presidential Award — the grand prize at this year’s Korea Space Culture Awards, the Ministry…
Kenya Ebola Cases Rise to 2 in One Family
Kenya confirmed its second Ebola case on Wednesday 14 October, a 39-year-old relative of the first patient who was already in a 21-day quarantine.
9L+ Ayushman Bharat registrations, Rs 118cr paid in claims: CM
Delhi govt has established around 415 Ayushman Arogya Mandirs, with a target of 1,100, while Jan Aushadhi medicines are now available at prices nearly 90% lower than market rates, Rekha Gupta said.